Search results
Anticancer Research is a peer-reviewed journal that publishes original research on all aspects of cancer. The journal does not provide an impact factor, but you can find the current issue, archive, and other publications on its website.
- Archive
Potential Transcriptomic Biomarkers for Predicting...
- Other Publications
I grant the International Institute of Anticancer Research...
- About Us
ANTICANCER RESEARCH was established in 1981 and is published...
- Subscribers
If you have any questions related to your online...
- Advertisers
We strongly believe that ANTICANCER RESEARCH can serve as a...
- Editorial Board
Section for Experimental Cancer Research, Clinical Research...
- In Vivo
Three Special Issues are coming in 2025: Circulating Tumor...
- Cancer Genomics & Proteomics
Visit the official website of the International Institute of...
- Archive
Anticancer Research is a peer-reviewed journal established in 1981. Its impact factor is 1.6, and it has a 5-year impact factor of 1.8, according to the journal metrics page.
3 wrz 2024 · Anticancer Research is a monthly journal on experimental and clinical oncology, published by International Institute of Anticancer Research. Its impact factor in 2022 is 2.04, ranking it in the Q2 category of medicine and cancer research.
ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).
Anticancer Research is a monthly peer-reviewed journal on experimental and clinical oncology. Find out its impact factor, number of articles, and detailed information on BioxBio website.
Anticancer Research publishes original papers and reviews on experimental and clinical cancer research since 1981. The journal is open access and indexed in all abstracting services, with no processing fees or language and style corrections.
ANTICANCER RESEARCH is an oncology journal with an impact factor of 1.6 and a 5-year impact factor of 1.8. It is ranked in the fourth quartile of oncology journals and is a subscription-based journal published in Greece.